CTLT

Catalent, Inc.

No insider bought or sold Catalent, Inc. in the last 12 months

$0Bought, 12 mo

$0Sold, 12 mo

Follow CTLT

CTLT over the last year

Prices for CTLT aren't in yet.

CTLT after insider buys

3 months after each buy, from the first price a copier could get.

2 buys have 3 months of prices so far. A record shows here at 3.

Congress

Members reported 6 trades in CTLT since 2023.

Every filing

144 insider filings since 2016, newest first

CTLTSell

Michelle R Ryan · Director

$167K−21.0%Nov 14

CTLTSell

David Mcerlane · Group Pres, Biologics

$120K−5.0%Sep 27

CTLTSell

Ricky Hopson · Pres BioProduct Delivery, CoS

$39K−2.0%Aug 5

CTLTSell

Scott Gunther · SVP, Quality, Reg. Affairs

$40K−2.0%Aug 5

CTLTSell

Joseph Anthony Ferraro · SVP, General Counsel and CCO

$36K−2.0%Aug 5

CTLTSell

Lisa Evoli · SVP and CHRO

$230K−9.0%Aug 5

CTLTSell

Aristippos Gennadios · Group Pres Pharma, Consumer

$70K−1.0%Aug 5

CTLTSell

Alessandro Maselli · President and CEO

$534K−5.0%Jul 30

CTLTSell

Matti Masanovich · SVP and CFO

$170K−8.0%Jul 10

CTLTSell

Ricky Hopson · Pres BioProduct Delivery, CoS

$76K−6.0%Jun 5

CTLTBuy

Michelle R Ryan · Director

$50K+102.0%Sep 5

CTLTBuy

John J Greisch · Exec Chair

$1.1M+72.0%Sep 1

CTLTSell

Alessandro Maselli · President and CEO

$92K−2.0%Aug 25

CTLTSell

Steven L Fasman · EVP and Chief Admin Officer

$36K−1.0%Aug 25

CTLTSell

Alessandro Maselli · President and CEO

$70K−2.0%Aug 3

CTLTSell

Steven L Fasman · EVP and Chief Admin Officer

$77K−2.0%Aug 3

CTLTSell

Manja Boerman · Pres BioModalities Division

$72K−9.0%May 3

CTLTSell

Mario Gargiulo · SVP, Ops, Biologics Europe

$34K−11.0%May 3

CTLTSell

Ricky Hopson · Pres Clinical Dev Supply Div

$32K−4.0%Jan 25

CTLTSell

Manja Boerman · Pres BioModalities Division

$40K−5.0%Dec 7

CTLTSell

Michael J Grippo · SVP, Strategy, Corp. Dev.

$161K−12.0%Nov 2

CTLTSell

Thomas W Hawkeswood · Pres Pharma Prod Delivery Div

$72K−15.0%Oct 12

CTLTSell

Ricky Hopson · Pres Clinical Dev Supply Div

$199K−11.0%Sep 2

CTLTSell

Michael A. Riley · Pres Bio Product Delivery Div

$259K−27.0%Aug 30

CTLTSell

Scott Gunther · SVP, Quality, Reg. Affairs

$171K−6.0%Aug 30

CTLTSell

Kay A Schmidt · SVP, Enterprise Functions

$136K−7.0%Aug 26

CTLTSell

Michael A. Riley · Pres Bio Product Delivery Div

$153K−14.0%Aug 26

CTLTSell

Ricardo Pravda · SVP and CHRO

$180K−8.0%Aug 26

CTLTSell

Alessandro Maselli · President and CEO

$479K−10.0%Aug 26

CTLTSell

Patricia Hunt · Pres Consumer Health Div

$35K−4.0%Aug 26

CTLTSell

Ricky Hopson · Pres Clinical Dev Supply Div

$156K−7.0%Aug 26

CTLTSell

Thomas W Hawkeswood · Pres Pharma Prod Delivery Div

$69K−10.0%Aug 26

CTLTSell

Scott Gunther · SVP, Quality, Reg. Affairs

$190K−7.0%Aug 26

CTLTSell

Michael J Grippo · SVP, Strategy, Corp. Dev.

$172K−8.0%Aug 26

CTLTSell

Aristippos Gennadios · Group Pres Pharma, Consumer

$170K−2.0%Aug 26

CTLTSell

Mario Gargiulo · SVP Global Ops Biologics

$163K−20.0%Aug 26

CTLTSell

Steven L Fasman · EVP and Chief Admin Officer

$496K−7.0%Aug 26

CTLTSell

John R Chiminski · Exec Chair

$4.0M−14.0%Aug 26

CTLTSell

Thomas P Castellano · SVP and CFO

$146K−7.0%Aug 26

CTLTSell

Lorenzo Carletti · SVP Global Ops Ph, Cons Hlth

$106K−17.0%Aug 26

CTLTSell

Manja Boerman · Pres BioModalities Division

$340K−17.0%Aug 26

CTLTSell

Jonathan Arnold · SVP, Chief Commercial Ofcr

$40K−1.0%Aug 26

CTLTSell

Kay A Schmidt · SVP, Enterprise Functions

$35K−2.0%Jul 28

CTLTSell

Ricardo Pravda · SVP and CHRO

$46K−3.0%Jul 28

CTLTSell

Alessandro Maselli · President and CEO

$87K−2.0%Jul 28

CTLTSell

Ricky Hopson · Pres, Clinical Dev, Supply

$97K−5.0%Jul 28

CTLTSell

Scott Gunther · SVP, Quality, Reg. Affairs

$91K−4.0%Jul 28

CTLTSell

Michael J Grippo · SVP, Strategy, Corp. Dev.

$85K−4.0%Jul 28

CTLTSell

Aristippos Gennadios · Group Pres Pharma, Consumer

$43KJul 28

CTLTSell

Mario Gargiulo · SVP Global Ops Biologics

$104K−18.0%Jul 28

Older filings

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.